Clinical and Immunologic Effects of Extracorporeal Cytokine Removal in Patients with Septic Shock: A Randomized Controlled Trial
Early initiation of extracorporeal hemoadsorption in patients with septic shock did not improve vasopressor requirements or clinical outcomes, and no effects on the immune response were observed.
Authors
- Nicolas Schlegel (ORCID: https://orcid.org/0000-0001-5705-3945)
- Florian Wedekink (ORCID: https://orcid.org/0000-0001-5773-1179)
- J Wischhusen
- Beatrice Haack
- Daniel Röder (ORCID: https://orcid.org/0000-0001-6805-9330)
- Johannes Herrmann (ORCID: https://orcid.org/0000-0002-2169-3761)
- Quirin Notz (ORCID: https://orcid.org/0000-0002-4042-4436)
- Michaela Gieselmann
- Clara Lendzian
- Christopher Lotz
- Patrick Meybohm
- Johannes Heckelmann
Institutions
- Universitätsklinikum Würzburg (DE)
Publication Details
- Journal
- Shock
- Published
- 2026-02-04
- DOI
- https://doi.org/10.1097/shk.0000000000002802
- Primary Topic
- Sepsis Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00